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Abstract
Background: Electronic health (e-Health) interventions are emerging as an effective alternative model for
improving secondary prevention of coronary artery disease (CAD). The aim of this study was to describe the
effectiveness of different modes of delivery and components in e-Health secondary prevention programmes on
adherence to treatment, modifiable CAD risk factors and psychosocial outcomes for patients with CAD.
Method: A systematic review was carried out based on articles found in MEDLINE, CINAHL, and Embase. Studies
evaluating secondary prevention e-Health programmes provided through mobile-Health (m-Health), web-based
technology or a combination of m-Health and web-based technology were eligible. The main outcomes measured
were adherence to treatment, modifiable CAD risk factors and psychosocial outcomes. The quality appraisal of the
studies included was conducted using the Joanna Briggs Institute critical appraisal tool for RCT. The results were
synthesised narratively.
Result: A total of 4834 titles were identified and 1350 were screened for eligibility. After reviewing 123 articles in full, 24
RCTs including 3654 participants with CAD were included. Eight studies delivered secondary prevention programmes
through m-Health, nine through web-based technology, and seven studies used a combination of m-Health and web-
based technology. The majority of studies employed two or three secondary prevention components, of which health
education was employed in 21 studies. The m-Health programmes reported positive effects on adherence to medication.
Most studies evaluating web-based technology programmes alone or in combination with m-Health also utilised
traditional CR, and reported improved modifiable CAD risk factors. The quality appraisal showed a moderate
methodological quality of the studies.
Conclusion: Evidence exists that supports the use of e-Health interventions for improving secondary prevention of CAD.
However, a comparison across studies highlighted a wide variability of components and outcomes within the different
modes of delivery. High quality trials are needed to define the most efficient mode of delivery and components capable
of addressing a favourable outcome for patients.
Trial registration: Not applicable.
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Background
e-Health is an emerging field of medical informatics, refer-
ring to the organisation and delivery of health services
and information using the Internet and related technolo-
gies [1], such as web-based technology and mobile health
(m-Health) [2, 3]. The term e-Health characterises a way
of working to improve direct healthcare such as monitor-
ing clinical signs, delivering peer support, as well as health
information and education, using information and com-
munication technology [1]. The European Society of Car-
diology (ESC) recommends the use of e-Health sources to
support remote clinical care and improve psychosocial
health, diet and smoking cessation, in both primary and
secondary prevention of coronary artery disease (CAD)
[2–4]. Secondary prevention programmes, focusing on
pharmacological and non-pharmacological treatment, play
a pivotal role in decreasing modifiable CAD risk factors as
well as improving adherence to treatment and quality of
life [4]. Despite the clinical benefits of secondary preven-
tion, only a minority of patients achieve control of modifi-
able CAD risk factors [5]. It is also known that adherence
to treatment in patients with CAD is suboptimal [6]. The
reasons for non-adherence are complex and involve fac-
tors related to psychosocial factors and social support.
Furthermore, secondary prevention programmes are
underutilised [7]. Only one-third of patients with CAD at-
tend some form of secondary prevention programme [5].
Geographical accessibility and shortcomings in the health-
care system are main issues for non-participation [7]. This
challenge underpins the need for the development of al-
ternative modes of delivery of secondary prevention pro-
grammes, such as e-Health programmes where patients
receiveaccess to resources at their discretion.
Among the alternative modes of e-Health secondary pre-
vention programme delivery reviewed previously, the indi-
vidual studies included have primarily focused on telehealth
such as telephone interventions [8, 9] and internet technol-
ogy including web-based and m-Health interventions [10,
11]. The most recent reviews brought some evidence of im-
proved quality of life, diet and physical activity. However,
due to the variations between key elements of the studies
included, they could not give any implications for practice
[10, 11]. A recent updated systematic review on telehealth
interventions for patients with CAD, which included more
diverse telehealth interventions such as internet and
m-Health, reported improved cardiovascular risk factors.
However, 60% of the studies included evaluated telephone
interventions [12]. To date, telephone interventions are
some of the most studied tools of telemedicine interven-
tions [13], but may require more resources than contem-
porary e-Health technology available. However, the use of
e-Health in secondary prevention for CAD is a rapidly
growing area and more evidence is therefore expected to
become available [11].
Although, a number of components for secondary pre-
vention programmes for CAD have been outlined and
standardised in European guidelines and position state-
ments [4, 14, 15], the e-Health secondary prevention
programmes seem to differ substantially in their specific
components. With regard to the feasibility of e-Health,
one systematic review displayed that only 10% of the
e-Health secondary prevention programmes included a
multicore component approach [16].
To date, no systematic reviews focusing primarily of the
effectiveness of m-health and web-based technology as
modes of e-Health delivery and its secondary prevention
components in patients with CAD have been published. To
inform the design of further e-Health secondary prevention
programmes, the aim of this systematic review was to
describe the effectiveness of different modes of delivery and
components for e-Health secondary prevention pro-
grammes on adherence to treatment, modifiable CAD risk
factors and psychosocial outcomes for patients with CAD.
Methods
To minimise potential sources of bias this systematic re-
view followed the Preferred Reporting Items for System-
atic Reviews and Meta-Analyses (PRISMA) guidelines
[17]. The protocol for this systematic review was regis-
tered in the International Prospective Register of System-
atic Reviews (PROSPERO) [18] (ID: 111927).
Eligibility criteria
The studies selected had to meet the specific eligibility cri-
teria presented in Table 1. Based on the definition of
e-Health [1] and a position statement of the ESC [3], the
eligibility criteria regarding the mode of e-Health second-
ary prevention programme delivery were defined a priori
and categorised into: (i) m-Health comprising mobile
phone applications and/or text messages, but excluding
telephone calls (ii) web-based technology applicable for
traditional desktop or laptop computers; and (iii) a com-
bination of m-Health and web-based technology. The
modes of e-Health delivery consist of screening, assess-
ment, self-monitoring, self-management, social support,
advice and education according to the secondary preven-
tion components.
Based on standardised secondary prevention programme
components defined by the British Association of Cardio-
vascular Prevention and Rehabilitation (BACPR) [19] and a
position paper from the European Association for Cardio-
vascular Prevention and Rehabilitation (EACPR) [14], this
review classified a priori the essential secondary prevention
programme components into: (i) Physical activity and exer-
cise management through exercise plans, supervision and
counselling; (ii) Health education regarding medical risk
management (blood pressure, lipids, glucose) and health
behaviour change (dietary habit, weight management,
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tobacco cessation, psychological management, physical ac-
tivity); (iii) Psychosocial management including counselling
on emotional issues, stress management and facilitation of
peer support; (iv) Self- monitoring of medical risk manage-
ment (blood pressure, lipids, glucose) and health behaviour
change (diet, weight, tobacco cessation, physical activity);
and (v) Medical risk management including education and
support on the use of cardioprotective medications and
adherence.
The effectiveness of the eligible studies were described
according to three broad categories of a priori defined
outcome measures: (i) Adherence to treatment, defined
as to what extent the patient follows a prescription (e.g.
taking medication, following a diet, and/or executing
lifestyle changes), that corresponds with agreed recom-
mendations from a healthcare professional [20]; (ii)
Modifiable CAD risk factors such as high blood pressure,
high blood cholesterol levels, smoking, overweight, phys-
ical inactivity and poor diet [4, 5]; and (iii) Psychosocial
outcomes, encompassing depression, anxiety, chronic
stress, social support and quality of life [21].
Search strategy
The search strategy was designed to locate eligible stud-
ies published in English over a 15-year period (January
2003 to March 2018). The interval was chosen to reflect
the time period in which the most relevant work in
e-Health for patients with CAD was published [10]. A
team of clinical researchers in the CONCARDPCI-study
and a PhD-prepared librarian (LBH) agreed upon a
search strategy for MEDLINE (Additional file 1: Table
S1.), which was then adapted for use in CINAHL and
Embase. Articles identified through referenced and hand
searches were considered for inclusion.
Study selection
All selected titles and abstracts were scanned independ-
ently by two researchers (GB and TRP) using a checklist
based on the eligibility criteria (Table 1) to identify
papers for potential inclusion. Disagreements regarding
the relevance of the abstract were resolved through
discussion. The full-text version of the article was obtained
and assessed when the abstract information was insuffi-
cient, or if one researcher found it necessary to see the
full-text version. The full-text versions of the articles were
obtained and assessed independently for eligibility by two
researchers (GB and TRP). Any disagreements were re-
solved through discussion or by consulting a third re-
searcher (TMN). The search process shown in the flow
diagram was based on the PRISMA statement [17] (Fig. 1).
Data extraction
The pre-planned data extraction was imported by one
researcher (GB) into an Excel spreadsheet. A second
researcher (TRP) assessed the data extraction for accuracy.
The Cochrane Consumers and Communication Review
Group’s data extraction template [22] was used to capture
all relevant information about the studies included. Study
characteristics were extracted using the Template for Inter-
vention Description and Replication (TIDieR) checklist [23].
Quality appraisal
The quality appraisal was systematically assessed by two
independent researchers (GB and TRP) using the Joanna
Briggs Institute (JBI) critical appraisal tool for RCTs.
The tool contains 13 items that assess the methodo-
logical quality of the design, conduct and analysis of
RCTs. The tool comprises four elemental answer choices
(Yes, No, Unclear and Not Applicable) [24]. If there was
insufficient information to answer a question, unclear
was recorded. In non-pharmacological trials, the blind-
ing of participants and health professionals in relation to
treatment assessment is not always possible [25]. There-
fore, criteria such as the blinding of participants and
those who delivered the intervention were considered
not applicable (NA) and the performance bias was
scored at high risk in all the studies. The results of the
quality appraisal assessment are reported in narrative
form and in a table for each aspect relating to methodo-
logical quality (Table 2).
Table 1 Inclusion and exclusion criteria for the studies included in the review
Patient Adult patients (≥18 years) with CAD
Type of intervention and setting e-Health secondary prevention programme alone or in addition to traditional secondary prevention care
Comparison Compared against the group that received traditional secondary prevention care
Mode of e-Health delivery m-Health; web-based technology; or a combination of m-Health and web-based technology
Secondary prevention components Physical activity and exercise management; Health education regarding medical; Psychosocial management;
Self- monitoring; and Medical risk management
Outcome Adherence to treatment, modifiable CAD risk factors; psychosocial outcomes
Design Randomized controlled trials
Exclusion criteria Interventions in the form of telephone calls; Interventions evaluating heart monitoring systems.
Abbreviations: CAD Coronary artery disease, e-Health Electronic health, m-Health Mobile Health
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Describing and analysing studies
Due to large variations between the studies included
in terms of key elements (secondary prevention
programme components, content delivery, intensity,
and outcomes measured between and within the three
different modes of e-Health delivery), a meta-analysis
was not performed [50]. Further, the studies did not
all address multiple risk factors. Using the narrative
synthesis methodology, essential modes of delivery
and components in e-Health secondary prevention
programmes for the effectiveness of outcomes were
identified and described. The ESRC methods
programme for narrative synthesis was used to collate
study findings into a coherent textual narrative, with
descriptions of the differences in the studies’ charac-
teristics [51]. The narrative synthesis process was
based on the conceptual framework of e-Health sec-
ondary prevention programmes, secondary prevention
programme components and outcomes defined a
priori as described in the section on eligibility criteria.
A preliminary synthesis was developed by organising
the findings from the studies included to describe
patterns across the studies using a textual description.
In parallel, the studies were grouped according to the
conceptual framework to describe relationships be-
tween various modes of e-Health delivery, secondary
prevention programme components and the outcome
measures of the evaluated studies. Two researchers
(GB and TRP) carried out the narrative synthesis
process.
Results
Characteristics of included studies
The trial selection process identified 4834 records,
while 1350 studies were screened for possible inclu-
sion and 123 full manuscripts were reviewed (Fig. 1).
In total, 21 completed RCTs in 24 publications that
fulfilled the eligibility criteria were included. The
studies included were conducted in Asia [32, 39],
Europe [26, 30, 31, 35, 40, 41, 43–48], North-America
[29, 36–38, 49], and Oceania [27, 28, 33, 34, 42]. A
total of 3654 participants (mean age 59.67) were re-
cruited, with the sample size ranging from 46 to 710.
Study characteristics are summarised in Table 3.
Fig. 1 Data selection process and results based on the PRISMA statement [14]
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As regards the theoretical framework, this was
described in 10 studies (12 publications); three ap-
plied a behavioural change technique [27, 28, 41], two
applied the self-efficacy theory of Bandura [37, 38],
two applied a patient-centred care approach [29, 31],
while the others applied Internet-Based Cognitive
Therapy (iCBT) [26], the Chronic Care Model [43],
the Social Cognitive Theory [33], and the m-Health
Development and Evaluation Framework [34]
(Table 4).
Half (54%) of the studies identified in this review
described the group of healthcare professionals deliv-
ering the e-Health secondary programme, including
nurses [37, 38, 41, 43, 49], a nurse and a physician
[31, 32], one nurse, exercise specialist and dietitian
[36] cardiologist [44], a health professional who had
coached cardiac patients for more than five years, su-
pervised by a cardiologist [35], psychologist [26], exer-
cise specialist [45], moderator [46], and a study
coordinator [29] (Table 4).
Table 2 Summary of quality appraisal systematically assessed by the Joanna Briggs Institute critical appraisal tool for randomized
controlled trials [24]
Author (year) 1 2 3 4 5 6 7 8 9 10 11 12 13 SUM
Norlund et al.2018 [26] Y Y Y NA NA U U Y Y Y Y Y Y 9
Thakkar et al. 2016 [27] Y Y Y NA NA U U Y U Y Y Y Y 8
Chow et al.2016 [28] Y Y Y NA NA Y U Y Y Y Y Y Y 10
Widmer et al. 2017 [29] Y U Y NA NA Y U Y U Y Y Y Y 9
Johnston et al. 2016 [30] Y U Y NA NA U U Y U Y Y Y Y 7
Wolf et al. 2016 [31] U U Y NA NA U U Y U Y Y Y Y 6
Fang et al. 2016 [32] Y U Y NA NA U U Y U Y Y Y Y 7
Pfaeffli Dale et al. 2015 [33] Y Y Y NA NA N U Y Y Y Y Y Y 9
Maddison et al. 2015 [34] Y U Y NA NA Y U Y Y Y Y Y Y 9
Frederix et al. 2015 [35] Y U Y NA NA Y U Y Y Y Y Y Y 9
Lear et al. 2015 [36] U U Y NA NA U U U U Y Y Y Y 5
Park et al. 2015 [37] Y Y Y NA NA U U Y Y Y Y Y Y 9
Park et al. 2014 [38] Y Y Y NA NA U U Y Y Y Y Y Y 9
Khonsari et al.2015 [39] U N Y NA NA U U Y Y Y Y Y Y 7
Frederix et al. 2015 [40] Y U Y NA NA U U Y U Y Y Y Y 7
Devi et al. 2014 [41] Y Y Y NA NA N U Y Y Y Y Y Y 9
Varnfield et al. 2014 [42] Y U Y NA NA U U Y Y Y Y Y Y 8
Vernooij et al. 2012 [43] U U Y NA NA U U Y U Y Y V Y 6
Blasco et al. 2012 [44] Y U Y NA NA U U Y Y Y Y Y Y 8
Reid et al. 2011 [45] Y Y Y NA NA U U Y U Y Y Y Y 8
Lindsay et al. 2009 [46] U U U NA NA U U U U Y Y U Y 3
Vieira et al. 2018 [47] Y U U NA NA U U Y U Y Y Y Y 6
Vieira et al. 2017 [48] Y U U NA NA U U Y U Y Y Y Y 6
Southard et al. 2003 [49] Y U Y NA NA U U Y U U Y Y Y 6
Abbreviation: NA Not Applicable, N No, U Unclear, Y Yes
Quality appraisal criteria: [24]
1. Was true randomization used for assignment of participants to treatment groups?
2. Was allocation to treatment groups concealed?
3. Were treatment groups similar at the baseline?
4. Were participants blind to treatment assignment?
5. Were those delivering treatment blind to treatment assignment?
6. Were outcomes assessors blind to treatment assignment?
7. Were treatment groups treated identically other than the intervention of interest?
8. Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and analyzed?
9. Were participants analyzed in the groups to which they were randomized?
10. Were outcomes measured in the same way for treatment groups?
11. Were outcomes measured in a reliable way?
12. Was appropriate statistical analysis used?
13. Was the trial design appropriate, and any deviations from the standard RCT design (individual randomization, parallel groups) accounted for in the conduct
and analysis of the trial.
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Description of the e-Health interventions
m-Health
Eight studies (n = 1513) utilised m-Health technology in-
cluding text messages, smart phone applications,
micro-letter applications and medication reminders to
deliver CAD-related health education, recommenda-
tions, self-monitoring and medication risk management
[27, 28, 30, 32, 37–39, 44] (Tables 3, 4 and 5). Seventy
five percent of the studies comprised applications and
text messages that provide health education and re-
minders for medical risk management and/or health be-
haviour change [27, 28, 30, 32, 37, 38] and one
employed medication risk management only [39]. One
study only employed self-monitoring [44] (Tables 4 and
5, and Fig. 2). Although text messages were the most
common to include, there was a diversity in the mate-
rials provided in all the studies. Two studies delivered
the m-Health secondary prevention programme in
addition to traditional exercise-based cardiac rehabilita-
tion (CR) [27, 28], one in addition to traditional second-
ary prevention care [30] and clinical visits [44] (Table 4).
Overall, the studies reported secondary prevention
programmes delivered by m-Health to be well accepted.
In five studies, acceptability was assessed using a feed-
back questionnaire following completion of the interven-
tion [27, 28, 30, 37, 38]. These studies demonstrated
high patient satisfaction with the intervention, where
91% reported it to be useful [28], 88.6% found it easy to
use [37, 38], and 97.5% would recommend the interven-
tion to others in the same situation [30]. One study
assessed acceptability of the intervention through the
number of sessions completed. Adherence to protocol was
reported to be high with 83% completing more than 75%
of the sessions [44]. Three studies did not provide data on
the acceptability of the intervention [27, 32, 39] (Table 3).
Effect of m-health interventions on outcomes
Adherence to treatment
Five studies assessed adherence to medications as the
primary outcome [30, 32, 37–39]. There was a
non-significant trend towards improved medication ad-
herence in one study [32]. Significant differences were
found in four studies [30, 37–39]. One study reported
that non-adherence scores were significantly lower in
the intervention group compared with the control group
when measured with an e-diary (16.6 vs 22.8, P = 0.025).
However, no difference in self-reported adherence was
found at the end of study visit as measured by the Medi-
cation Adherence Report Scale (MARS-5) [30]. Regard-
ing antiplatelet medications, two publications reported a
higher number of doses taken (P = 0.003), correct doses
taken (P = 0.047) and doses taken on schedule (P =
0.004) [37, 38]. Furthermore, one study demonstrated
significantly higher medication adherence levels in the
intervention group (P < 0.001) for patients with acute
coronary syndrome as measured by the Morisky Medica-
tion Adherence Scale (MMAS-8) [39] (Tables 3, 4 and 5,
and Fig. 2).
Modifiable CAD risk factors
Four studies utilising m-Health measured modifiable
CAD risk factors. There was a diversity of risk factors
assessed in the studies. Three studies assessed physical
activity [27, 28, 30]. Of these, two studies assessed
self-reported physical activity at baseline and follow-up
by using the Global Physical Activity Questionnaire
(GPAQ) [27, 28]. One study reported higher recreational
physical activity (471 vs. 307 metabolic equivalent-min/
week, P < 0.001), and higher work-related physical activ-
ity and lower sedentary times (494 vs. 587min, P <
0.001) in favour of the intervention group [27]. Further,
one study reported that patients in the intervention
group exercised more regularly compared with the con-
trol group (P < 0.001) [28]. In one study, physical activity
was registered in an e-diary. The use of an e-diary did
not result in between-group differences in physical activ-
ity [30] (Tables 3, 4 and 5, and Fig. 2).
Of the three studies that assessed smoking cessation
[28, 30, 44], one study reported significant differences
between groups in favour of the intervention group (P <
0.001) [28]. As regards the cardiovascular risk profile,
one study reported that more patients in the intervention
group achieved treatment goals for blood pressure (62.1% vs
42.9%, P= 0.012) and HbA1c (86.4% vs 54.2%, P= .0018). In
addition, BMI was significantly lower in the intervention
group (P= 0.005) [44] (Tables 3, 4 and 5, and Fig. 2).
Psychosocial outcomes
Three studies utilising m-Health assessed psychosocial
outcomes [30, 37, 44]. No significant differences were
found for anxiety and depression [44], quality of life [30]
or medication self-efficacy [37] (Tables 3, 4 and 5, and
Fig. 2).
Web-based
Nine studies (n = 1209) utilised web-based technologies,
ranging from web-portals with written information,
modules or tutorials regarding CAD-related risk factors,
to moderated online discussion groups and chat sessions
with health professionals [26, 36, 41, 43, 45–49] (Tables
3 and 4). Seven studies employed health education [26,
36, 41, 43, 45, 46, 49] in combination with physical activ-
ity and exercise management [36, 45],
psychosocial-management [26, 41, 46], self-monitoring
[26, 36, 41, 43, 45, 46, 49] and medication care manage-
ment [43]. One web-based technology programme
employed physical activity and exercise management as
Brørs et al. BMC Health Services Research          (2019) 19:364 Page 15 of 24
a single component [47, 48] (Tables 3, 4 and 5, and Fig.
2). One web-based secondary prevention programme
was delivered as an adjunct to usual care [43] (Table 4).
The completion rate of the interventions varied sub-
stantially. One study reported that 54% completed the
introductory module. Furthermore, 0.9% (1/117) com-
pleted the recommended 14 steps within the 14-week
treatment period [26]. In four studies, completion rates
varied from 43 to 83% [41, 45, 47, 48]. In one study, pa-
tient satisfaction was assessed through a semi-structured
interview at the end of the programme. In this study, the
intervention was perceived to be an accessible, conveni-
ent and effective way of delivering healthcare services
[36]. Further, one study reported high patient satisfac-
tion, where the patients were ‘very satisfied’ with the
programme and reported it to be ‘very helpful’ [49]. One
Table 5 Relationships within and between studies on various modes of delivery and components of the evaluated studies















Thakkar et al. 2016
[27]
✓ ✓ ✓ +
Chow et al. 2015 [28] ✓ ✓ ✓ +
Johnston et al. 2016
[30]
✓ ✓ ✓ + – –
Park et al. 2015 [37] ✓ ✓ ✓ + –
Park et al. 2014 [38] ✓ ✓ ✓ +
Khonsari et al. 2015
[39]
✓ ✓ +
Fang et al. 2016 [32] ✓ ✓ ✓ –
Blasco et al. 2012
[44]
✓ ✓ + –
Southard et al. 2003
[49]
✓ ✓ ✓ + –
Lindsay et al. 2009
[46]
✓ ✓ ✓ +
Devi et al. 2014 [41] ✓ ✓ ✓ ✓ + +
Norlund et al. 2018
[26]
✓ ✓ ✓ ✓ –
Reid et al. 2012 [45] ✓ ✓ ✓ ✓ + +
Lear et al. 2015 [36] ✓ ✓ ✓ ✓ +
Vieira et al. 2018 [47] ✓ ✓ –
Vieira et al. 2017 [48] ✓ ✓ +
Vernooij et al. 2012
[43]
✓ ✓ ✓ ✓ –
Widmer et al. 2017
[29]
✓ ✓ ✓ ✓ + –
Wolf et al. 2016 [31] ✓ ✓ ✓ – +
Pfaeffli Dale et
al.2015 [33]
✓ ✓ ✓ ✓ + – –
Maddison et al. 2015
[34]
✓ ✓ ✓ ✓ ✓ + +
Frederix et al. 2015
[40]
✓ ✓ ✓ ✓ +
Frederix et al. 2015
[35]
✓ ✓ ✓ ✓ + +
Varnfield et al. 2014
[42]
✓ ✓ ✓ + + +
Abbreviations: CAD Coronary artery disease, HE Health education, MM Medical risk management, PA/EM Physical activity and exercise management; PM
Psychological management; SM Self-monitoring. +: Significant change in outcome; −: No significant change in outcome
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study reported that 152 patients logged in at a median
of 56 times during the year. However, the monthly num-
ber of logins decreased during the intervention period
[43]. Data on acceptability was not reported in one study
[46] (Table 3).
Effect of web-based interventions on outcomes
Modifiable CAD risk factors
Seven studies assessed a variety of modifiable CAD risk
factors [36, 41, 43, 45, 46, 48, 49]. Six studies assessed
physical activity [36, 41, 43, 45, 46, 49]. One study
assessed improvement in physical capacity through
changes in maximum time on the treadmill stress test
(MTT). The intervention group reported a greater in-
crease in MTT by 45.7 s (95% CI: 1.0, 90.5) compared
whit usual care (P = 0.045) [36]. Two studies [41, 45]
assessed physical activity through changes in the average
daily step count. In both studies, the intervention group
significantly improved their daily step count. One study
reported effects from the intervention at the six week
follow-up (+ 497 steps), whereas the control group had
decreased their number of steps (− 861 steps) (95% CI
263–2451, P = 0.02). However, no effects of the interven-
tion were present at six months [41]. Further, one study
reported that the intervention group had significantly in-
creased objectively measured (P = 0.023) and
self-reported physical activity (P = 0.047) compared with
the intervention group [45]. Two studies utilised
self-report alone to assess physical activity. No signifi-
cant between-group differences were reported [46, 49]
(Tables 3, 4 and 5, and Fig. 2).
In terms of the cardiovascular risk profile, systolic and
diastolic blood pressure following completion of the
programme were reported in two studies [41, 49]. One
study reported no significant between-group differences
[49], whereas one study reported a significant reduction
in systolic blood pressure for the control group com-
pared with the intervention group (ES = 0.68, 95% CI
2.99–13.91, P = 0.001) [41]. No significant differences
were reported in diastolic blood pressure [41]. Three
studies reported cholesterol levels [36, 48, 49]. In one
study, intra-group analysis revealed a significant increase
in high-density lipoproteins (HDL) in intervention group
one (t = − 3.281, P = 0.017) [48]. One study reported that
Fig. 2 Relationships within and between studies on various modes of delivery, components and significant effect on outcomes of the
evaluated studies
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total cholesterol and low density lipoprotein (LDL) levels
were 7% (P = 0.026) and 12% (P = 0.022) lower, respect-
ively. However, differences were no longer significant
when adjusting for potential confounders [36]. Further,
one study found no significant between-group differ-
ences in cholesterol levels [49] (Tables 3, 4 and 5, and
Fig. 2).
Five studies reported smoking status [36, 41, 45, 46,
49]. Of these, two studies reported smoking status at
baseline [36, 41]. One study reported smoking status at
baseline and 52 weeks. However, it is unclear whether
the results are statistically significant [45]. Two studies
found no significant between-group differences [46, 49]
(Tables 3, 4 and 5, and Fig. 2).
Two studies assessed weight reduction [41, 49]. Both
studies reported significant differences with P = 0.003
[49] and P = 0.02 [41]. However, for one study, no effects
of the intervention were present at 6-months follow-up
[41]. Three studies reported BMI [36, 48, 49]. One study
reported a significant reduction in BMI (P = 0.003) [49].
Further, one study found no significant differences in
BMI [48], while one study reported the baseline charac-
teristics of participants [36]. Three studies assessed diet-
ary habits [36, 41, 46]. One study reported a decrease in
fat intake (ES = 0.30, 95% CI –6.12 to 1.80, P = 0.28) and
an increase in fibre intake (ES = 0.29, 95% CI–2.23 to
8.53, P = 0.25) at six weeks. However, these differences
were not present at 6-months follow-up [41]. One study
reported that participants in the intervention group had
1.6% kcal/day higher dietary protein and 1.4% kcal/day
lower dietary saturated fat, P = 0.004 and P = 0.018 re-
spectively. These differences remained statistically sig-
nificant after adjusting for confounders, P = 0.003 and P
= 0.018, respectively [36]. One study found no significant
between-group differences [46]. One study assessed
modifiable CAD risk factors through relative change in
Framingham heart risk score at one year. A relative
change of − 12% (− 22 to − 3%) in Framingham heart
risk score for the intervention group compared with
the usual care group was reported. Furthermore, a
difference between groups was observed in low dens-
ity lipoprotein cholesterol (− 0.3, − 0.5 to − 0.1, mmol/
L) and smoking (− 7.7, − 14.9 to − 0.4%) [43] (Tables
3, 4 and 5, and Fig. 2).
Psychosocial outcomes
Five studies assessed psychosocial outcomes, including
anxiety and depression, quality of life and stress [26, 41,
45, 47, 49]. Only two studies demonstrated significant
between-group differences in psychosocial outcomes [41,
45]. One study found significant benefits in the social
quality of life score (95% CI 0.05–0.54, P = .02) at
6-month follow-up in favour of the intervention group
[41]. Similarly, another study reported higher emotional
dimensions of heart disease health-related quality of life
in the intervention group (P = 0.038) [45]. One study re-
ported a reduction in anxiety and depression scores over
time in the total study sample (mean delta = − 5.1, P
< .001), but no difference between the study groups at
follow-up (beta = − 0.47, 95% CI − 1.95 to 1.00, P = 0.53).
Furthermore, no effect of treatment was found on the
secondary outcomes (severe depression, suicidal idea-
tion, cardiac anxiety) at the follow-up [26]. In two stud-
ies, no significant differences were found for quality of
life or anxiety and depression [47, 49] (Tables 3, 4 and 5,
and Fig. 2).
Combining m-health and web-based technology
Seven studies (n = 913) combined m-Health and
web-based technology to deliver health education,
self-monitoring and reporting systems, automated feed-
back from text messages or email, chat functions, and
physical activity and exercise management [29, 31, 33–
35, 40, 42] (Tables 3 and 4, and Fig. 2). Six studies
employed health education [29, 33–35, 40, 42] in com-
bination with: physical activity and exercise management
[35, 40], psychosocial-management [29, 31, 33, 34] and
self-monitoring [29, 33–35, 40, 42]. One study employed
psychosocial management in combination with
self-monitoring [31] (Tables 4 and 5, and Fig. 2). Five
studies delivered a combination of m-Health and
web-based secondary prevention programmes as an ad-
junct to traditional CR [29, 33–35, 40] and as an adjunct
to a person-centred face-to-face care approach [31]
(Table 4).
Overall, the acceptability of the combined m-Health
and web-based technology programmes was good. One
study demonstrated high patient satisfaction, where 95%
reported to be ‘satisfied’ or ‘very satisfied’ with the
programme [35]. Similarly, two studies reported that
82–85% read some or all text messages [33, 34], and
79% of participants felt that the programme was of the
right length [33]. Completion rates of the interventions
varied from 73% [29] to 80% [42]. One study reported
that 39% chose to use the intervention and continued to
use it at least once after discharge from hospital [31].
Data on acceptability was not reported in one study [35]
(Table 3).
Effect of combining m-Health and web-based technology
on outcomes
Adherence to treatment
Two studies assessed adherence to treatment, more spe-
cifically adherence to healthy lifestyle behaviours (pri-
mary outcome) and medications (secondary outcome)
[33], and adherence to an exercise-based cardiac re-
habilitation programme [42]. For the primary outcome,
one study reported a significant treatment effect in
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favour of the intervention at three months (AOR 2.55,
95% CI 1.12–5.84, P = 0.3), but not at six months (AOR
1.93, 95% CI 0.83–4.53, P = 0.13). For the secondary out-
come, medication adherence scores as measured by
MMAS-8 were significantly higher in the intervention
group (mean difference: 0.58, 95% CI 0.19–0.97, P =
0.004) [33]. One study reported that uptake was 1.3
times higher in the intervention group (80%) than in the
control group (62%) (P < 0.005), the intervention group
was 1.4 times more likely to adhere to the programme
(RR 1.71; 95% CI 1.13–2.27, P < 0.005), and completion
of the programme was 33% higher in the intervention
group [42] (Tables 3, 4 and 5, and Fig. 2).
Modifiable CAD risk factors
All studies assessed modifiable CAD risk factors. How-
ever, there were a diversity of risk factors assessed in the
studies. Six studies assessed physical activity [29, 31, 34,
35, 40, 42]. Of these, three studies assessed aerobic cap-
acity (VO2 peak) as the primary outcome [34, 35, 40],
and one study as the secondary outcome [29]. Two stud-
ies reported a significant increase in VO2 peak in favour
of the intervention group, P < 0.001 and P = 0.013, re-
spectively [35, 40] whereas two studies reported no sig-
nificant between-group differences (difference − 0.2 ml−
1kg min − 1, 95% CI: -1.1, 0.7: P = 0.65) [34] and P = 0.67
[29]. However, significant improvements in self-reported
leisure time physical activity (difference 110.2 min/week,
95% CI: _0.8, 221.3; P = 0.05) and walking (difference
151.4 min/ week, 95% CI: 27.6, 275.2; P = 0.02) at 24
weeks were reported in one study [34]. One study used
the six-minute walk test (6MWT) to assess physical cap-
acity. Both intervention groups showed significant im-
provements in 6MWT from baseline to 6 weeks (TCR:
537 ± 86–584 ± 99 m; CAP-CR: 510 ± 77–570 ± 80 m),
which was maintained at 6 months. However,
between-group differences for changes in 6MWT were
not significant at 6-month follow-up [42]. One study re-
ported no significant between-group differences regard-
ing physical activity [31] (Tables 3, 4 and 5, and Fig. 2).
Three studies assessed weight reduction [29, 35, 40].
One study reported a significant difference in weight in
favour of the intervention group (− 5.1 ± 6.5 kg vs. − 0.8
± 3.8 kg, P = 0.02), which was mirrored in the results for
BMI and waist circumference [29]. Two studies reported
no between-group differences regarding weight, BMI
or waist circumference [35, 40] (Tables 3, 4 and 5,
and Fig. 2).
Five studies reported systolic and diastolic blood pres-
sure at the end of the programme [29, 33, 35, 40, 42].
One study reported significant improvements in diastolic
blood pressure (P = 0.03), but not in systolic blood pres-
sure (P = 0.4) [42]. Four studies reported no significant
between-group differences in systolic or diastolic blood
pressure [29, 33, 35, 40].
Five studies reported HDL and LDL cholesterol levels
[29, 33, 35, 40, 42]. However, no studies reported signifi-
cant between-group differences for these parameters.
Similarly, no significant between-group differences were
reported regarding HbA1c [29, 35, 40].
One study reported a significant treatment effect in
favour of the intervention group regarding adherence to
recommended health guidelines at three months (AOR
2.55, 95% CI 1.12–5.84; P = 0.03), but not at six months
(AOR 1.93, 95% CI 0.83–4.53; P = 0.13) [33] (Tables 3, 4
and 5, and Fig. 2).
Psychosocial outcomes
Six studies assessed psychosocial outcomes, including
anxiety and depression, self-efficacy, quality of life and
stress [29, 31, 33–35, 42]. One study reported significant
improvements in global health-related quality of life for
the intervention group (P < 0.001). Between-group com-
parison confirmed that the intervention group improved
more than the control group (U = 2407, z = 2.805, P =
0.01) [35]. One study reported reductions in psycho-
logical distress as measured by Kessler 10 (K10) Psycho-
logical Distress Scale (median (IQR) 14.6 (13.4–16.0) to
12.6 (11.5–13.8)), as well as significant improvements in
the EQ5D-Index for the intervention group at the end of
the programme (six weeks). However, these differences
were not significant at 6-month follow-up [42]. One
study reported a significant improvement in mean
self-efficacy levels as measured by the General
Self-Efficacy Scale (GSES) for the intervention group (P
= 0.011) [31]. Further, one study reported significantly
higher quality of life scores as measured by the Dart-
mouth Quality of Life Index (P = 0.03). However, no sig-
nificant differences were found regarding stress and
depression [29]. One study reported significant improve-
ments in self-efficacy to be active (difference 6.2, 95%
CI: 0.2,12.2; p = 0.04) and the general health domain of
the SF-36 (difference 2.1, 95% CI: 0.1, 4.1; p = 0.03) [34].
Furthermore, one study reported a negative effect for
total hospital anxiety as the intervention group reported
greater anxiety than the control group at six months
(mean difference: 1.18, 95% CI 0.28–2.08, P = 0.01) [33]
(Tables 3, 4 and 5, and Fig. 2).
Quality appraisal
On average, the studies included had a moderate meth-
odological quality, with scores ranging from three to 13
(median 8) (Table 2). True randomisation was used for
the assignment of participants to treatment groups in 21
studies. In three studies, the randomisation procedure
was insufficiently reported (selection bias) [31, 39, 46].
The major risk of bias in the studies included was due
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to insufficuent blinding of participants, those who deliv-
ered the intervention (performance bias) and assessors
(measurement bias). There was also a risk of allocation
bias due to the treatment of interest. Half of the studies
included in the review reported that participants were
analysed in the groups to which they were randomised
(attribution bias). The detailed quality appraisal of the
studies included, systematically assessed by use of the
JBI critical appraisal tool for RCTs [24], is given in
Table 2.
Discussion
The current systematic review identified, appraised and
synthesised 24 publications that evaluated e-Health sec-
ondary prevention programmes and their effects on ad-
herence to treatment, modifiable CAD risk factors and
psychosocial outcomes for patients with CAD. The qual-
ity of these studies was moderate (median score of eight
as measured by the JBI critical appraisal tool). Further,
there was heterogeneity in terms of secondary preven-
tion components, content delivery, intensity and out-
comes measured between and within the three different
modes of e-Health delivery.
In summary, web-based technology applicable for
desktop or laptop computers was the most frequently
used mode of e-Health delivery. Eight studies delivered
m-Health secondary prevention programmes. Unlike
that described in previous reviews [10, 11], seven studies
combined web-based and m-Health technology. This
finding shows a trend towards utilising all available tech-
nology when designing and implementing e-Health sec-
ondary prevention programmes for patients with CAD
[10, 52]. Further, the acceptability of the combination of
m-Health and web-based technology was high compared
whit web-based technology alone, which varied substan-
tially. However, the majority of the studies combining
m-Health and web-based technology, delivered the
programme as an adjunct to traditional CR and/or usual
care [29, 31, 33–35, 40], which could have affected the
acceptability in relation to the in-person approaches. Of
those studies, all reported some level of effectiveness in
at least one of three outcome categories defined a priori.
A previous meta-analysis [12] reported that telehealth
delivered in combination with traditional CR showed
favourable changes in secondary prevention for patients
with CAD of medium and long-term duration. However,
many of those studies were telephone-based and the
numbers of participants in traditional CR was moderate
to low [12]. Notably, another previous review that
assessed evidence from an e-Health secondary preven-
tion programme versus traditional centre-based CR for
CAD, found no difference in outcomes between the two
modes of delivery [8]. These reviews recommended that
e-Health could be offered to patients who cannot attend
traditional CR [8] or as an adjunct [12]. It has also been
described that e-Health secondary prevention pro-
grammes would decrease non-participation and the
dropout rate due to better adaptation to the patients’
needs and preferences [7]. Therefore, based on know-
ledge of barriers associated with non-participation and
dropout from traditional secondary prevention pro-
grammes, more research is needed to develop feasible
modes of e-Health delivery which provide increased
flexibility in relation to time and geographical location.
In terms of secondary prevention programme compo-
nents, this review demonstrated that health education
was the most frequently provided secondary prevention
component. This differs from older reviews, which re-
port that physical activity and exercise management
were most frequently evaluated [8, 16]. This development
is in line with the updated document from BACPR, which
recognises that the educational component remains fun-
damental to all other secondary prevention programme
components to increase self-management and healthy be-
haviour [15, 19]. Utilisation of e-Health technology in edu-
cation delivery provides easier access and patients can
self-pace through educational materials. However,
patient-related barriers such as low electronic health liter-
acy are of importance to the patients’ ability to apply
knowledge, make appropriate decisions and achieve better
self-management behaviour [2]. None of the studies that
included health education assessed in this review aimed to
specifically address the electronic health literacy skills
needed in an e-Health context, although, one web-based
programme [41] reported positive improvement in
self-efficacy, which is an indicator of health literacy [53].
However, an m-Health secondary prevention programme
based on self-efficacy theory reported non-significant im-
provement in medication self-efficacy. The intervention
delivered consisted of medication reminders and health
education through text messages [37]. The lack of im-
provement may be associated with psychosocial factors
and low socioeconomic status, which are reported as bar-
riers for digital health adoption [2].
This review identified two web-based studies and four
studies combining web-based and m-Health that report
positive effects on psychosocial outcomes. It may be dis-
cussed whether psychosocial health management gets
too little attention in the development of e-Health sec-
ondary prevention programmes. Despite this, it is well
known that depression, anxiety and low quality of life
are common among patients with CAD [4, 26] and psy-
chosocial health is recommended as a standard compo-
nent in secondary prevention programmes [4, 15].
Psychosocial factors cannot be underestimated in terms
of their impact on medication adherence, behavioural
change and self-management. One study that aimed to
reduce negative emotions by providing advice about
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stress and anxiety management skills and social support
[41] reported favourable changes in emotional and social
quality of life. The study demonstrates that a web-based
mode of psychosocial management and support delivery
can be feasible in secondary prevention for CAD. Further,
this review has identified viable tools, such as feedback
messages, chat sessions and online discussion groups, that
employ web-based technology to replace face-to-face
meetings. To improve health outcomes, the e-Health sys-
tem should be designed to foster effective interactions be-
tween patients and health professionals. However, little is
known about whether social support offered through
e-Health programmes has the same effect on
self-management behaviour and psychosocial outcomes as
traditional secondary prevention programmes [54].
In terms of medication adherence, a previous review
identified seven positive RCTs published in the period
2012–2015 [55]. This review identified an additional four
studies that utilis m-Health interventions published after
2015 [27, 28, 30, 32], of which one study reported a posi-
tive trend for medication adherence [30]. This finding
shows a potential for using m-Health to improve medica-
tion adherence. According to studies providing a combin-
ation of m-Health and web-based technology, one study
reported a positive short-term effect on medication adher-
ence [33]. It is surprising however, that studies combining
m-Health and web-based technology did not utilise the
technology available by providing medical risk manage-
ment. This finding shows a need for more rigorous studies
utilising the combination of different modes of e-Health
technology available to improve medication adherence.
Within the mode of m-Health delivery positive effects
were reported on physical activity [27, 28] and smoking
cessation [28] in the TEXT ME trial. To our knowledge,
no previous reviews evaluating the effect of m-Health
secondary prevention programmes on cardiovascular
diseases have reported studies demonstrating positive ef-
fects on smoking cessation [55, 56]. Unlike other
m-Health interventions assessed, the TEXT ME trial was
based on the behavioural change technique, which may
be a determining factor for success. Interventions based
on behavioural change theory tend to be more effective
than those without a theoretical framework [57]. Using
principles from behaviour change theories in the devel-
opment of m-Health secondary prevention programmes
may increase the likelihood of success [58]. A number of
theoretical frameworks offer guidance on how to man-
age mechanisms of change in individual health-related
behaviour patterns in the development of complex inter-
ventions. However, it is unclear whether and how the
use of theory influences the effectiveness of e-Health in-
terventions [57], and most studies assessed in this review
did not clearly describe the underlying theoretical frame-
work. Therefore, more studies that apply a theoretical
framework that is made explicit in the reporting are
needed. Several useful frameworks exist. For example,
the UK Medical Research Council’s (MRC) revised
framework [59] can be used to guide the complex
e-Health secondary programme development. Another
alternative could be the eHealth Enhanced Chronic Care
Model (Model (eCCM). The eCCM is a further develop-
ment of the Chronic Care Model (CCM) that included
self-management support and clinical information sys-
tems as two of its key elements in order to provide
technological skills, access to data, information and
knowledge needed to improve health [54]. Further, since
it is proposed that behaviour change occurs when pa-
tients are well informed, highly motivated and have the
skills necessary to perform self-management behaviour
[60], e-Health literacy is of relevance. The e-Health liter-
acy model aims to empower patients and enable them to
fully participate in health decisions informed by different
modes of e-Health delivery [53], and could be an alter-
native when developing health education as a compo-
nent of e-Health secondary prevention programmes.
The strengths of this review include its systematic ap-
proach to data collection. The Cochrane Consumers and
Communication Review Group’s data extraction tem-
plate [22] was used to capture all relevant information
about the studies included. Study characteristics were
extracted using the TIDieR checklist [23]. The quality
appraisal was systematically assessed by two independent
researchers (GB and TRP) using the JBI critical appraisal
tool for RCTs [24]. PRISMA guidelines [17] for reporting
systematic reviews were used to minimise potential
sources of bias. Articles identified through referenced
and hand searches were also considered for inclusion.
Nevertheless, the review was limited to empirical re-
search published in the English language. There may
also be unpublished theses or conference proceedings
that were overlooked. Furthermore, as the literature
search did not yield any results from Latin America or
Sub-Saharan Africa, no studies from these countries
were included in this review, thus reducing the general-
isability of the results for these populations. However,
this systematic review is merely the first step towards
developing new and innovative e-Health interventions
relating to follow-up care for patients with CAD.
Conclusion
This systematic review shows that evidence exists to
support the use of e-Health secondary prevention pro-
grammes for patients with CAD. However, comparison
across studies highlighted a wide variability of secondary
prevention programme components and outcomes
within the different modes of delivery. High quality trials
are needed to define the most efficient mode of delivery
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and components capable of addressing a favourable out-
come for patients.
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